United States $1.74 Bn Endometrial Cancer Markets, Competition, Forecast and Opportunities, 2028F
January 31, 2024 04:56 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "United States Endometrial Cancer Market, Competition, Forecast and Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's...
Endometrial Cancer Market Growing Significantly | AstraZeneca, Karyopharm, Evergreen therapeutics, ImmunoGen, Inc., Merck, Tesaro, Inc., Abbott, Roche, Chimerix, Bayer, ImmunoGen, Inc., Incyte, Eli Lilly, Gilead, Genentech Expected to Boost
April 03, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, April 03, 2023 (GLOBE NEWSWIRE) -- Endometrial Cancer Market Growing Significantly | AstraZeneca, Karyopharm, Evergreen therapeutics, ImmunoGen, Inc., Merck, Tesaro, Inc., Abbott,...